 Effects indomethacin hepatogenic pulmonary angiodysplasia patient cirrhosis marked hypoxemia administration indomethacin mg/day days mm Hg mm Hg time dynamic pulmonary perfusion plateau time course curve MAA uptake lungs findings state severe hypoxemia indomethacin observations part hepatogenic pulmonary angiodysplasia functional vasodilatation vasoactive substances prostaglandins eicosanoids